Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q4 2023 vs. Q3 2023
How the institutions holding Biofrontera Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| Shares | 16.2K | 9.46K | −6.77K (−41.7%) |
| Value | $142.2K | $26.2K | −$116.1K (−81.6%) |
New holders (3)
Institutions that held Biofrontera Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,173 | $8.79K | 0.00% |
| Morgan Stanley | 200 | $554 | 0.00% |
| Bank of America Corp | 11 | $30 | 0.00% |
Sold out (3)
Institutions that held Biofrontera Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Vanguard Group Inc | 10,954 | $96.1K |
| Cary Street Partner Investment Advisory LLC | 25 | $219 |
| UBS Group AG | 1 | $9 |